The Trump administration's plan to cap indirect costs for NIH-funded medical research at 15% has caused serious concern in research labs nationwide. Dr. Donald Milton of the University of Maryland, who focuses on respiratory viruses, explains that such a limitation could critically impair their work and slow down research progress. The NIH, already facing workforce reductions and managing a substantial $48 billion budget, relies heavily on indirect costs to fund research outside its agency, making this proposal particularly alarming for future medical advancements.
Dr. Donald Milton warns that the proposed cap on indirect costs could severely undermine research on respiratory viruses, ultimately hindering efforts to manage their transmission.
The Trump administration's initiative poses a significant threat to funding for medical research, with universities like the University of Maryland facing potential staffing reductions and slowed research efforts.
Collection
[
|
...
]